Swiss Life Asset Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Hold |
0
| – | – | – | 75 |
|
|
2026
Q1 | – | Sell |
-786,755
| Closed | -$75.6M | – | 1574 |
|
|
2025
Q4 | $75.6M | Sell |
786,755
-66,041
| -8% | -$6.41M | 0.39% | 48 |
|
|
2025
Q3 | $81.2M | Buy |
+852,796
| New | +$78.4M | 0.42% | 42 |
|
|
2025
Q2 | – | Sell |
-846,597
| Closed | -$71.8M | – | 47 |
|
|
2025
Q1 | $76.1M | Buy |
846,597
+24,077
| +3% | +$2.15M | 0.55% | 36 |
|
|
2024
Q4 | $65.7M | Buy |
822,520
+530,861
| +182% | +$46M | 0.48% | 41 |
|
|
2024
Q3 | $26.3M | Buy |
291,659
+213
| +0.1% | +$17.9K | 0.3% | 73 |
|
|
2024
Q2 | $22.9M | Buy |
291,446
+15,154
| +5% | +$1.24M | 0.27% | 78 |
|
|
2024
Q1 | $24.1M | Buy |
276,292
+53,434
| +24% | +$4.56M | 0.33% | 66 |
|
|
2023
Q4 | $18.4M | Buy |
222,858
+90,714
| +69% | +$6.91M | 0.22% | 103 |
|
|
2023
Q3 | $10.4M | Sell |
132,144
-29,207
| -18% | -$2.44M | 0.16% | 154 |
|
|
2023
Q2 | $14.2M | Sell |
161,351
-23,823
| -13% | -$2.05M | 0.21% | 108 |
|
|
2023
Q1 | $14.9M | Buy |
185,174
+483
| +0.3% | +$39.4K | 0.22% | 102 |
|
|
2022
Q4 | $14.4M | Sell |
184,691
-17,796
| -9% | -$1.44M | 0.24% | 104 |
|
|
2022
Q3 | $16.3M | Buy |
202,487
+36,788
| +22% | +$3.31M | 0.28% | 77 |
|
|
2022
Q2 | $14.9M | Sell |
165,699
-77,029
| -32% | -$7.8M | 0.24% | 91 |
|
|
2022
Q1 | $26.9M | Buy |
242,728
+8,295
| +4% | +$876K | 0.38% | 53 |
|
|
2021
Q4 | $24.3M | Sell |
234,433
-10,371
| -4% | -$1.2M | 0.32% | 71 |
|
|
2021
Q3 | $30.7M | Buy |
244,804
+15,332
| +7% | +$1.98M | 0.43% | 48 |
|
|
2021
Q2 | $31.5M | Buy |
229,472
+4,096
| +2% | +$514K | 0.32% | 48 |
|
|
2021
Q1 | $26.6M | Buy |
225,376
+8,054
| +4% | +$944K | 0.38% | 53 |
|
|
2020
Q4 | $25.5M | Sell |
217,322
-103,160
| -32% | -$11.4M | 0.37% | 53 |
|
|
2020
Q3 | $33.3M | Buy |
320,482
+504
| +0.2% | +$50.6K | 0.49% | 41 |
|
|
2020
Q2 | $29.3M | Sell |
319,978
-41,816
| -12% | -$4.01M | 0.47% | 46 |
|
|
2020
Q1 | $32.6M | Buy |
361,794
+62,933
| +21% | +$6.7M | 0.62% | 36 |
|
|
2019
Q4 | $33.9M | Sell |
298,861
-176,413
| -37% | -$19.4M | 0.64% | 36 |
|
|
2019
Q3 | $51.6M | Sell |
475,274
-168,539
| -26% | -$17.6M | 0.67% | 36 |
|
|
2019
Q2 | $62.7M | Buy |
643,813
+55,860
| +10% | +$5.1M | 0.76% | 30 |
|
|
2019
Q1 | $53.6M | Buy |
587,953
+17,213
| +3% | +$1.54M | 0.68% | 34 |
|
|
2018
Q4 | $51.9M | Sell |
570,740
-30,784
| -5% | -$2.88M | 1.06% | 23 |
|
|
2018
Q3 | $59.2M | Buy |
601,524
+12,908
| +2% | +$1.19M | 0.79% | 27 |
|
|
2018
Q2 | $50.4M | Sell |
588,616
-19,795
| -3% | -$1.65M | 0.75% | 25 |
|
|
2018
Q1 | $48.8M | Buy |
608,411
+12,951
| +2% | +$1.07M | 0.85% | 20 |
|
|
2017
Q4 | $48.1M | Buy |
+595,460
| New | +$47.7M | 1.07% | 17 |
|
|
2017
Q3 | – | Sell |
-472,707
| Closed | -$39.2M | – | 16 |
|
|
2017
Q2 | $42M | Buy |
472,707
+9,289
| +2% | +$783K | 1.08% | 12 |
|
|
2017
Q1 | $37.3M | Buy |
463,418
+137,295
| +42% | +$10.7M | 1.01% | 17 |
|
|
2016
Q4 | $23.2M | Buy |
326,123
+148,488
| +84% | +$11.7M | 0.78% | 35 |
|
|
2016
Q3 | $15.3M | Buy |
177,635
+57,210
| +48% | +$4.99M | 0.52% | 51 |
|
|
2016
Q2 | $10.4M | Buy |
120,425
+4,857
| +4% | +$393K | 0.43% | 66 |
|
|
2016
Q1 | $8.67M | Hold |
115,568
| – | – | 0.37% | 74 |
|
|
2015
Q4 | $8.89M | Sell |
115,568
-1,700
| -1% | -$128K | 0.4% | 69 |
|
|
2015
Q3 | $7.85M | Buy |
117,268
+10,240
| +10% | +$754K | 0.38% | 71 |
|
|
2015
Q2 | $7.93M | Sell |
107,028
-5,101
| -5% | -$390K | 0.28% | 74 |
|
|
2015
Q1 | $8.74M | Buy |
+112,129
| New | +$8.5M | 0.35% | 67 |
|
Other funds holding MDT
Swiss Life Asset Management's MDT Position: Q2 2026 in Review
Swiss Life Asset Management held its Medtronic (MDT) position steady in Q2 2026 at 0 shares worth $63.3M. The position accounts for 0.26% of the portfolio, ranked #75.
Swiss Life Asset Management first reported a position in MDT in Q1 2015 and has held it in 42 quarters since. The position peaked at $81.2M in Q3 2025. 1,653 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Swiss Life Asset Management held 0 shares of Medtronic worth $63.3M as of Q2 2026.
- Swiss Life Asset Management left its Medtronic share count unchanged in Q2 2026.
- Medtronic made up 0.26% of Swiss Life Asset Management's portfolio in Q2 2026, its #75 holding.
- Swiss Life Asset Management first reported a position in Medtronic in Q1 2015 and has held it in 42 quarters since.
- Swiss Life Asset Management's Medtronic position peaked at $81.2M in Q3 2025.
- 1,653 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.